Case Report
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 6, 2020; 8(23): 6206-6212
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.6206
Novel triple therapy for hemorrhagic ascites caused by endometriosis: A case report
Xue Han, Shi-Tai Zhang
Xue Han, Shi-Tai Zhang, Gynecology Department, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China
Author contributions: Han X and Zhang ST contributed equally to this work, analyzed the case, wrote the manuscript, and read and approved the final manuscript.
Informed consent statement: All study participants provided informed written consent prior to study enrollment.
Conflict-of-interest statement:  The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shi-Tai Zhang, MD, PhD, Attending Doctor, Lecturer, Gynecology Department, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Shenyang 110004, Liaoning Province, China. zhangshitai@126.com
Received: August 10, 2020
Peer-review started: August 10, 2020
First decision: August 21, 2020
Revised: September 13, 2020
Accepted: September 25, 2020
Article in press: September 25, 2020
Published online: December 6, 2020
Core Tip

Core Tip: We for the first time report a case of endometriosis-related massive ascites treated with a novel triple therapy including conservative surgery, gonadotropin-releasing hormone agonist, and dienogest, which offers a new possibility to treat the disease.